Revofil

Revofil is a leading brand of dermal fillers renowned for their innovative use of biomimetic peptides. Developed by Caregen, Revofil products are designed to remodel and contour facial tissues, offering exceptional results in facial rejuvenation. Clinics and doctors worldwide trust Revofil for its high-quality, effective formulations that cater to diverse patient needs.

The Revofil range encompasses three primary products:

• Revofil Fine: Ideal for treating soft lines, Revofil Fine is formulated with 23 mg/ml of Hyaluronic Acid (HA). It is perfect for correcting superficial wrinkles, fine lines, and caved scars. This filler is injected into the superficial dermis and offers long-lasting results, typically around 10 months.
• Revofil Plus: This filler is designed to add volume and contour the face. With 23 mg/ml of HA, it addresses medium to deep wrinkles and folds. Injection areas include the forehead, nose bridge, nasolabial folds, marionette lines, lips, cheeks, and jaw. Revofil Plus is injected into the mid to deep dermis and provides results lasting up to 12 months.
• Revofil Ultra: For more intensive volume and deep filling, Revofil Ultra is the choice. It contains 23 mg/ml of HA and targets very deep wrinkles in thick skin tissue. Injection areas include the forehead, nose bridge, nasolabial folds, marionette lines, cheeks, lips, jaw, and chin. This product is injected into the deep to subcutaneous dermis, ensuring a duration of up to 12 months.

Revofil’s advanced fillers combine biphasic and monophasic characteristics thanks to cutting-edge biomimetic peptide technology and cross-linked hyaluronic acid. This unique combination enhances the gel’s viscosity and elasticity, ensuring a softer, more comfortable procedure for patients. The use of biomimetic peptides not only boosts the filler’s performance but also increases its duration by inhibiting endogenous Hyaluronidase, giving patients long-lasting and natural-looking results.